LCID
Lucid Group, Inc.
LCID has a slight edge over PRPL overall, supported by stronger fundamentals and lower modeled downside.
PRPL
Purple Innovation, Inc.
PRPL offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
PRPL Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Under pressure | |
| Strong |
PRPL's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
PRPL PE Valuation
PRPL has no meaningful PE right now: it lost money over the past year.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
PRPL Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect PRPL's losses to shrink, with revenue growing.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
PRPL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$8.82 | +$4.43 |
| Q2 2026 | -$11.24 | +$8.26 |
| Q1 2026 | -$14.50 | +$1.00 |
| Q4 2025 | -$12.00 | +$10.75 |
| Q3 2025 | -$13.25 | +$11.96 |
| Q2 2025 | -$19.50 | +$5.21 |
| Q1 2023 | -$28.50 | -$11.75 |
| Q4 2022 | -$27.50 | -$20.00 |
PRPL has the edge over LCID on earnings, with more consistent year-over-year improvement.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over PRPL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
PRPL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.5M | -19% |
| Q2 2026 | $98.3M | -6.5% |
| Q1 2026 | $95.7M | -8.1% |
| Q4 2025 | $140.7M | +9.1% |
| Q3 2025 | $118.8M | +0.1% |
| Q2 2025 | $105.1M | -13% |
| Q1 2025 | $104.2M | -13% |
| Q4 2024 | $129M | -12% |
PRPL's revenue has slid since its 2020 peak: $97M last quarter, down 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -10% | +0.1 points |
| Q2 2026 | -4.3% | +9.2 points |
| Q1 2026 | -18% | -3.7 points |
| Q4 2025 | -1.6% | +4.4 points |
| Q3 2025 | -10% | +29 points |
| Q2 2025 | -14% | -1.5 points |
| Q1 2025 | -14% | +5.4 points |
| Q4 2024 | -6% | +5.1 points |
PRPL has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
PRPL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $5.3M | +$7.2M |
| Q2 2026 | -$1.3M | +$5.7M |
| Q1 2026 | $1.4M | +$26.7M |
| Q4 2025 | -$7.8M | -237% |
| Q3 2025 | -$1.8M | -1904% |
| Q2 2025 | -$7M | +$4M |
| Q1 2025 | -$25.3M | -$5.5M |
| Q4 2024 | $5.7M | +$10.2M |
PRPL has the edge over LCID on cash flow, with more consistent year-over-year improvement.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
PRPL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2021 | -1.7x | Net Cash |
| Q2 2021 | -1.2x | Net Cash |
| Q1 2021 | -0.7x | Net Cash |
| Q4 2020 | -1.0x | Net Cash |
| Q3 2020 | -0.8x | Net Cash |
| Q2 2020 | -1.0x | Net Cash |
| Q1 2020 | 0.4x | Very low |
| Q4 2019 | 0.1x | Very low |
PRPL has more cash than debt.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
PRPL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 24.8 | Oversold |
| Stochastic | 6.2 | Oversold |
PRPL's weekly RSI is 25 (oversold) and its Stochastic is 6 (oversold).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
PRPL PE vs Consumer Cyclical Sector
PRPL has no meaningful PE right now: it lost money over the past year.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
PRPL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.28 | 28% below |
| 20 week MA | $4.75 | 65% below |
| 50 week MA | $11.2 | 85% below |
| 100 week MA | $16.3 | 90% below |
| 200 week MA | $31.8 | 95% below |
PRPL is in a downtrend: it's below all five of its weekly moving averages, and 95% below its 200-week average.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has the edge over PRPL on returns for 2026, with the stronger performance.
PRPL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $212.5 | $850.5 | +300% |
| 2021 | $850.5 | $337.5 | -60% |
| 2022 | $337.5 | $120.8 | -64% |
| 2023 | $120.8 | $25.8 | -79% |
| 2024 | $25.8 | $21.0 | -18% |
| 2025 | $21.0 | $18.4 | -12% |
| 2026 YTD | $18.4 | $1.65 | -91% |
PRPL has finished five years in a row lower, and it's down 91% so far in 2026.